PacBio (PACB) director Kathy Ordonez receives 223,492 stock options at $1.58
Rhea-AI Filing Summary
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. director Kathy Ordonez received a grant of stock options covering 223,492 shares of common stock. The options have an exercise price of $1.58 per share, were granted at no cost, and expire on June 3, 2036.
These options vest monthly over one year, or earlier on the date of the next annual meeting of stockholders after the grant date, as long as she continues to serve as a director through each vesting date. Following this grant, her reported stock option holdings from this award total 223,492 shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
ORDONEZ KATHY
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 223,492 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 223,492 shares (Direct)
Footnotes (1)
- F1. The shares subject to the option will vest monthly over one (1) year, on the same day of the month as the date of grant or, if earlier, on the date of the next annual meeting of the Company's stockholders occurring after the date of grant, provided such Reporting Person continues to serve as a director through the applicable vesting dates.
Key Figures
Stock options granted: 223,492 shares
Exercise price: $1.58 per share
Expiration date: June 3, 2036
+2 more
5 metrics
Stock options granted
223,492 shares
Grant of stock options to director on June 3, 2026
Exercise price
$1.58 per share
Exercise price for the granted stock options
Expiration date
June 3, 2036
Option term end for this grant
Shares underlying options
223,492 shares
Common stock underlying the derivative award
Shares held after transaction
223,492 options
Total derivative holdings from this award following grant
Key Terms
Stock Option (right to buy), grant/award acquisition, exercise price, vest monthly, +1 more
5 terms
Stock Option (right to buy) financial
"security_title: "Stock Option (right to buy)""
grant/award acquisition financial
"transaction_action: "grant/award acquisition""
exercise price financial
"conversion_or_exercise_price: "1.5800""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest monthly financial
"The shares subject to the option will vest monthly over one (1) year"
Common Stock financial
"underlying_security_title: "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did PACB director Kathy Ordonez report?
Kathy Ordonez reported receiving a grant of stock options for 223,492 shares of Pacific Biosciences common stock. The options were granted at no cost, represent compensation, and give her the right to buy shares at a fixed exercise price of $1.58.
What is the exercise price of Kathy Ordonez’s new PACB stock options?
The new stock options have an exercise price of $1.58 per share. This means she can purchase Pacific Biosciences common stock at $1.58 per share once options vest, regardless of the market price at that time, until the options expire.
When do Kathy Ordonez’s PACB stock options vest?
The options vest monthly over one year starting from the grant date. Vesting can also complete earlier on the date of the next annual stockholders’ meeting, as long as she continues serving as a director through the relevant vesting dates.
When do Kathy Ordonez’s PACB stock options expire?
The stock options expire on June 3, 2036. She can exercise vested options any time before that expiration date, subject to Pacific Biosciences’ plan rules and her continued eligibility under the terms of the grant and board service conditions.